T. C. Merigan

6.9k total citations
128 papers, 5.6k citations indexed

About

T. C. Merigan is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, T. C. Merigan has authored 128 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 38 papers in Virology and 36 papers in Infectious Diseases. Recurrent topics in T. C. Merigan's work include HIV Research and Treatment (37 papers), Cytomegalovirus and herpesvirus research (34 papers) and Herpesvirus Infections and Treatments (28 papers). T. C. Merigan is often cited by papers focused on HIV Research and Treatment (37 papers), Cytomegalovirus and herpesvirus research (34 papers) and Herpesvirus Infections and Treatments (28 papers). T. C. Merigan collaborates with scholars based in United States, Germany and Canada. T. C. Merigan's co-authors include Lucy Rasmussen, Erik De Clercq, David Katzenstein, Mark A. Winters, Robert W. Shafer, Anthony L. Cunningham, Ann M. Arvin, Wolfgang K. Joklik, Mark Holodniy and Robert M. Nelson and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

T. C. Merigan

125 papers receiving 5.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
T. C. Merigan 2.5k 1.8k 1.7k 1.5k 885 128 5.6k
Gerald V. Quinnan 2.7k 1.1× 2.1k 1.2× 1.3k 0.8× 2.3k 1.6× 661 0.7× 116 5.6k
Herbert Schmitz 1.5k 0.6× 926 0.5× 3.1k 1.8× 669 0.5× 910 1.0× 183 5.4k
Jody Manischewitz 3.1k 1.2× 1.6k 0.9× 1.1k 0.6× 2.1k 1.5× 916 1.0× 77 5.0k
T. C. Merigan 1.1k 0.5× 952 0.5× 1.0k 0.6× 1.2k 0.9× 473 0.5× 89 3.7k
Jörg Schüpbach 1.3k 0.5× 2.7k 1.5× 2.3k 1.3× 1.7k 1.1× 536 0.6× 100 5.2k
M. La Plaça 1.3k 0.5× 1.5k 0.8× 984 0.6× 1.3k 0.9× 831 0.9× 268 4.4k
Henri Agut 3.3k 1.3× 1.6k 0.9× 1.9k 1.1× 1.1k 0.8× 421 0.5× 200 5.6k
Ruth M. Ruprecht 1.8k 0.7× 4.3k 2.4× 2.1k 1.2× 2.5k 1.7× 1.4k 1.6× 179 6.6k
R. V. Blanden 1.4k 0.5× 604 0.3× 1.2k 0.7× 3.3k 2.3× 956 1.1× 144 5.8k
Ronald C. Kennedy 862 0.3× 1.1k 0.6× 754 0.4× 1.8k 1.2× 1.5k 1.6× 161 4.7k

Countries citing papers authored by T. C. Merigan

Since Specialization
Citations

This map shows the geographic impact of T. C. Merigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. C. Merigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. C. Merigan more than expected).

Fields of papers citing papers by T. C. Merigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. C. Merigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. C. Merigan. The network helps show where T. C. Merigan may publish in the future.

Co-authorship network of co-authors of T. C. Merigan

This figure shows the co-authorship network connecting the top 25 collaborators of T. C. Merigan. A scholar is included among the top collaborators of T. C. Merigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. C. Merigan. T. C. Merigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schapiro, Jonathan, Jody Lawrence, Roberto F. Speck, et al.. (1999). Resistance Mutations to Zidovudine and Saquinavir in Patients Receiving Zidovudine plus Saquinavir or Zidovudine and Zalcitabine plus Saquinavir in AIDS Clinical Trials Group 229. The Journal of Infectious Diseases. 179(1). 249–253. 9 indexed citations
2.
Katzenstein, David, et al.. (1999). Delayed-Type Hypersensitivity to Recombinant HIV Envelope Glycoprotein (rgp160) After Immunization With Homologous Antigen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(4). 341–341. 7 indexed citations
3.
Winters, Mark A., Yvette A. Girard, Hasnah Hamdan, et al.. (1998). A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.. Journal of Clinical Investigation. 102(10). 1769–1775. 195 indexed citations
4.
Rasmussen, Lucy, Christina Hong, Donato Zipeto, et al.. (1997). Cytomegalovirus gB Genotype Distribution Differs in Human Immunodeficiency Virus--Infected Patients and Immunocompromised Allograft Recipients. The Journal of Infectious Diseases. 175(1). 179–183. 74 indexed citations
5.
Merigan, T. C., et al.. (1997). Heterogeneity of cytokine functions in HIV infection. Immunology. 91(2). 234–238. 4 indexed citations
6.
Rasmussen, Lucy, Shannon R. Morris, Donato Zipeto, et al.. (1995). Quantitation Of Human Cytomegalovirus DNA From Peripheral Blood Cells Of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus Retinitis. The Journal of Infectious Diseases. 171(1). 177–182. 83 indexed citations
7.
Rasmussen, Lucy, Shannon R. Morris, Richard A. Wolitz, et al.. (1994). Deficiency In Antibody Response To Human Cytomegalovirus Glycoprotein Gh In Human Immunodeficiency Virus-Infected Patients At Risk For Cytomegalovirus Retinitis. The Journal of Infectious Diseases. 170(3). 673–677. 24 indexed citations
8.
Katzenstein, David, et al.. (1994). Quantitation of Human Immunodeficiency Virus by Culture and Polymerase Chain Reaction in Response to Didanosine after Long-Term Therapy with Zidovudine. The Journal of Infectious Diseases. 169(2). 416–419. 25 indexed citations
9.
Wood, Robin, et al.. (1993). Safety and Efficacy of Polyethylene Glycol-Modified Interleukin-2 and Zidovudine in Human Immunodeficiency Virus Type 1 Infection: A Phase I/II Study. The Journal of Infectious Diseases. 167(3). 519–525. 38 indexed citations
10.
Reid, T., T. C. Merigan, & Teresa Y. Basham. (1992). Resistance to Interferon-α in a Mouse B-Cell Lymphoma Involves DNA Methylation. Journal of Interferon Research. 12(2). 131–137. 7 indexed citations
11.
Winters, Mark A., Mark Holodniy, David Katzenstein, & T. C. Merigan. (1992). Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.. Genome Research. 1(4). 257–262. 10 indexed citations
12.
Holodniy, Mark, et al.. (1991). Detection and Quantification of Human Immunodeficiency Virus RNA in Patient Serum by Use of the Polymerase Chain Reaction. The Journal of Infectious Diseases. 163(4). 862–866. 133 indexed citations
13.
Basham, Teresa Y., et al.. (1991). Intermittent, Alternating, and Concurrent Regimens of Zidovudine and 2'-3'dideoxycytidine in the LP-BM5 Murine Induced Immunodeficiency Model. The Journal of Infectious Diseases. 163(4). 869–872. 16 indexed citations
14.
Basham, Teresa Y., et al.. (1990). Zidovudine (AZT) Reduces Virus Titer, Retards Immune Dysfunction, and Prolongs Survival in the LP-BMS Murine Induced Immunodeficiency Model. The Journal of Infectious Diseases. 161(5). 1006–1009. 27 indexed citations
15.
Basham, Teresa Y., et al.. (1988). Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action.. The Journal of Immunology. 141(8). 2855–2860. 18 indexed citations
16.
Keay, S., Lucy Rasmussen, & T. C. Merigan. (1988). Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope.. The Journal of Immunology. 140(3). 944–948. 30 indexed citations
17.
Keay, S., et al.. (1988). Topical Interferon for Treating Condyloma Acuminata in Women. The Journal of Infectious Diseases. 158(5). 934–939. 44 indexed citations
18.
Choo, Yew Cheong, C. Hsu, WH Seto, et al.. (1985). Intravaginal application of leukocyte interferon gel in the treatment of cervical intraepithelial neoplasia (CIN). Archives of Gynecology and Obstetrics. 237(1). 51–54. 10 indexed citations
19.
Egbert, P. R., et al.. (1978). Treatment of cytomegalovirus infection with intravenous ARA-A. Investigative Ophthalmology & Visual Science. 17. 1 indexed citations
20.
Jordan, George W., et al.. (1974). Administration of Human Leukocyte Interferon in Herpes Zoster. I. Safety, Circulating Antiviral Activity, and Host Responses to Infection. The Journal of Infectious Diseases. 130(1). 56–62. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald V. Quinnan Breakdown of academic impact, for papers by Herbert Schmitz Breakdown of academic impact, for papers by Jody Manischewitz Breakdown of academic impact, for papers by T. C. Merigan Breakdown of academic impact, for papers by Jörg Schüpbach Breakdown of academic impact, for papers by M. La Plaça Breakdown of academic impact, for papers by Henri Agut Breakdown of academic impact, for papers by Ruth M. Ruprecht Breakdown of academic impact, for papers by R. V. Blanden Breakdown of academic impact, for papers by Ronald C. Kennedy
Rankless by CCL
2026